| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1153316V |
| P356 | DOI | 10.1371/JOURNAL.PONE.0153316 |
| P932 | PMC publication ID | 4836711 |
| P698 | PubMed publication ID | 27092776 |
| P5875 | ResearchGate publication ID | 301534050 |
| P50 | author | Josef S Smolen | Q66753681 |
| František Špoutil | Q42318175 | ||
| Guenter Steiner | Q45738278 | ||
| P2093 | author name string | Jozef Rovensky | |
| Zdenko Killinger | |||
| Richard Imrich | |||
| Adela Penesova | |||
| Miroslav Vlcek | |||
| Ivana Jochmanova | |||
| Ivica Lazurova | |||
| Branislav Vohnout | |||
| Katarina Krskova | |||
| Andrea Marko | |||
| Katarina Raslova | |||
| Lucia Vernerova | |||
| Milada Meskova | |||
| P2860 | cites work | Population structure and eigenanalysis | Q21145248 |
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Measurement of patient outcome in arthritis | Q56879288 | ||
| Genetic variants in the prediction of rheumatoid arthritis | Q56899453 | ||
| Association of Variants inIL2RAWith Progression of Joint Destruction in Rheumatoid Arthritis | Q56968478 | ||
| TRAF1polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians | Q57330723 | ||
| Preferential Association of Interferon Regulatory Factor 5 Gene Variants with Seronegative Rheumatoid Arthritis in 2 Swedish Case-Control Studies | Q57537059 | ||
| The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis | Q58234961 | ||
| Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis | Q58912774 | ||
| Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis | Q37087883 | ||
| Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment | Q37131883 | ||
| Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. | Q37206056 | ||
| Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes | Q37223270 | ||
| Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls | Q37270770 | ||
| Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci | Q37388847 | ||
| Recent progress in rheumatoid arthritis genetics: one step towards improved patient care | Q37443734 | ||
| Rheumatoid arthritis and metabolic syndrome | Q38236740 | ||
| Measures of human population structure show heterogeneity among genomic regions | Q40509741 | ||
| A genome-wide screen of gene-gene interactions for rheumatoid arthritis susceptibility | Q42685398 | ||
| Revisiting the clinical validity of multiplex genetic testing in complex diseases | Q42930728 | ||
| Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins | Q44687984 | ||
| PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population | Q46584884 | ||
| Activation of interferon regulatory factor 5 by site specific phosphorylation | Q24307504 | ||
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis | Q24812184 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
| Genetics of rheumatoid arthritis contributes to biology and drug discovery | Q29417000 | ||
| New susceptibility loci associated with kidney disease in type 1 diabetes | Q29417066 | ||
| A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis | Q29417158 | ||
| High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis | Q30419111 | ||
| Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset | Q31031177 | ||
| The effect of multiple genetic variants in predicting the risk of type 2 diabetes | Q33519326 | ||
| Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region | Q33868008 | ||
| The rheumatoid arthritis HLA-DRB1 shared epitope | Q34067135 | ||
| PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population | Q34081898 | ||
| Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk | Q34103237 | ||
| Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers | Q34125266 | ||
| Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study | Q34156559 | ||
| Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis | Q34250412 | ||
| Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records | Q34458840 | ||
| The Disease Activity Score and the EULAR response criteria | Q34651201 | ||
| CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance | Q34654251 | ||
| Genotype score in addition to common risk factors for prediction of type 2 diabetes | Q34884376 | ||
| Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis | Q34897056 | ||
| Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking | Q34998359 | ||
| Mixed lymphocyte cultures in rheumatoid arthritis | Q35200536 | ||
| Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations | Q35553712 | ||
| CTLA4 gene polymorphism and autoimmunity | Q36079873 | ||
| Association between PADI4 and rheumatoid arthritis: a meta-analysis | Q36383132 | ||
| Genome-wide linkage and positional association analyses identify associations of novel AFF3 and NTM genes with triglycerides: the GenSalt study. | Q36600473 | ||
| Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients | Q36679775 | ||
| Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking | Q36790341 | ||
| Non-replication and inconsistency in the genome-wide association setting | Q36841272 | ||
| Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis | Q37046219 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | e0153316 | |
| P577 | publication date | 2016-04-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study | |
| P478 | volume | 11 |
| Q90150217 | Associations of TRAF1/C5 rs10818488 and rs3761847 polymorphisms with genetic susceptibility to rheumatoid arthritis: a case-control study and updated meta-analysis |
| Q41470976 | IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors |
| Q92570188 | KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
| Q59791524 | Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based? |
| Q33591346 | Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis |
Search more.